Combinations of therapeutic agents for treating cancer

Details for Australian Patent Application No. 2005316652 (hide)

Owner Novartis AG Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

Inventors Pisano, Claudio; Versace, Richard William; Zaknoen, Sara; Woo, Margaret Ma; Vesci, Loredana

Agent Davies Collison Cave

Pub. Number AU-B-2005316652

PCT Pub. Number WO2006/065780

Priority 60/636,439 15.12.04 US

Filing date 13 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 23 July 2009

International Classifications

A61K 31/4745 (2006.01)

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/065780 Priority application(s): WO2006/065780

23 July 2009 Application Accepted

  Published as AU-B-2005316652

19 November 2009 Standard Patent Sealed

16 August 2012 Assignment Registered

  Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.; Novartis AG The patent has been assigned to Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316668-Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors

2005316646-Inter-facet implant